超越免疫检查点抑制剂:黑色素瘤治疗中的新兴目标
Andrew D Knight1, Jason J Luke2
1University of Pittsburgh Medical Center, 3459 Fifth Ave. Room W-927, Pittsburgh, PA, 15213, USA.
Current oncology reports
|May 24, 2024
概括
新的黑色素瘤治疗方法正在出现,包括新型免疫疗法,细胞因子,瘤病毒,疫苗,双特异性抗体和采用细胞疗法. 这些有前途的黑色素瘤疗法正在进入临床试验.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 在过去的十年中,黑色素瘤治疗有了显著的进化.
- 针对BRAF的向疗法和免疫检查点抑制剂已经彻底改变了黑色素瘤护理.
- 一部分患者对当前的治疗没有反应,突出显示了尚未满足的需求.
研究的目的:
- 提供关于黑色素瘤治疗的最新进展的全面更新.
- 突出目前正在开发的针对黑色素瘤的有希望的新疗法.
- 提高对新兴黑色素瘤干预措施的认识.
主要方法:
- 审查最近的科学文献和临床试验数据.
- 专注于超越当前免疫检查点抑制剂的新型免疫疗法.
- 探索新兴策略,包括细胞因子,型病毒,疫苗,双特异性抗体和采用细胞疗法.
主要成果:
- 对黑色素瘤患者的治疗选择显著扩大.
- 在现有成功的基础上开发新型免疫疗法.
- 对新兴疗法的前临床和早期临床试验结果充满希望.
- 许多新型治疗方法正在进入关键的第三阶段研究.
结论:
- 黑色素瘤治疗领域正在迅速发展,有许多有前途的新疗法.
- 新兴的治疗方法,如新的检查点抑制剂,细胞因子,型病毒,疫苗,双特异性抗体和采用细胞疗法,显示出显著的潜力.
- 持续的研究和临床试验对于将这些创新的黑色素瘤治疗方法带给患者至关重要.
相关概念视频
Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Vaccines
355
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
355
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K


